[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acute-adult-t-cell-leukemia-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Acute Adult T-Cell Leukemia\u002FLymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04301076","Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)",[11],"Phase 1","RECRUITING","2026-08-26T02:16:08.402952Z","2026-07-19T19:36:05.132850Z",[],[]]